US-based Advocate Christ Medical Centre has deployed capnography respiratory monitoring, in a bid to protect patients on pain medication.
Capnography is the monitoring of concentration or partial pressure of carbon dioxide (CO2) in respiratory gases. It serves as a monitoring tool during anaesthesia and intensive care.
The hospital expanded the use of capnography to monitor patients using patient-controlled analgesia (PCA) to regulate their pain after surgery.
PCA is claimed to provide an effective way to control pain by allowing patients to self-administer small doses of pain medication intravenously, but the technology is expected to create risks because the medications used can also suppress the patient’s breathing.
Advocate Christ Medical Centre anaesthesia chairman Dr Boarden said: "Advocate Christ Medical Center is committed to providing the very highest quality patient care.
"Our widespread use of capnography to monitor a patient’s breathing is in line with the latest recommendations and underscores our dedication to patient safety."
Capnography is said to provide the earliest indication of evolving respiratory compromise, which can lead to significant morbidity or cardiopulmonary arrest if undetected.
It specifically measures how effectively patients are breathing by measuring exhaled CO2, allowing medical caregivers to minimise life-threatening respiratory depression.
Part of Advocate Health Care, Advocate Christ Medical Centre is a not-for-profit and 694-bed teaching institution that offers multiple specialities, including cardiovascular services, heart, kidney and lung transplantation, neurosciences, oncology, orthopaedics and women’s health.